Your browser doesn't support javascript.
loading
STAT1 activation in association with JAK2 exon 12 mutations.
Godfrey, Anna L; Chen, Edwin; Massie, Charles E; Silber, Yvonne; Pagano, Francesca; Bellosillo, Beatriz; Guglielmelli, Paola; Harrison, Claire N; Reilly, John T; Stegelmann, Frank; Bijou, Fontanet; Lippert, Eric; Boiron, Jean-Michel; Döhner, Konstanze; Vannucchi, Alessandro M; Besses, Carlos; Green, Anthony R.
Afiliação
  • Godfrey AL; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, Addenbrooke's Hospital, UK Department of Haematology, University of Cambridge, Cambridge, UK.
  • Chen E; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, University of Cambridge, Cambridge, UK.
  • Massie CE; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, University of Cambridge, Cambridge, UK.
  • Silber Y; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, University of Cambridge, Cambridge, UK.
  • Pagano F; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, University of Cambridge, Cambridge, UK.
  • Bellosillo B; Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain.
  • Guglielmelli P; Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
  • Harrison CN; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Reilly JT; Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK.
  • Stegelmann F; University Hospital of Ulm, Department of Internal Medicine III, Germany.
  • Bijou F; Institut Bergonie, Department of Hematology, Bordeaux, France.
  • Lippert E; Laboratoire d'Hematologie, CHU de Bordeaux and Laboratorie Hematopoiese Leucemique et Cibles Thérapeutiques, INSERM U 1035, Universite Bordeaux Segalen, Bordeaux, France.
  • Boiron JM; University of Bordeaux, Etablissement Français du Sang, France.
  • Döhner K; University Hospital of Ulm, Department of Internal Medicine III, Germany.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
  • Besses C; Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain.
  • Green AR; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, Addenbrooke's Hospital, UK Department of Haematology, University of Cambridge, Cambridge, UK arg1000@cam.ac.uk.
Haematologica ; 101(1): e15-9, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26635038
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Éxons / Mutação de Sentido Incorreto / Fator de Transcrição STAT1 / Janus Quinase 2 / Trombocitemia Essencial Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Éxons / Mutação de Sentido Incorreto / Fator de Transcrição STAT1 / Janus Quinase 2 / Trombocitemia Essencial Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido